CoChat

More rigour needed in trials of new diagnostic agents for tuberculosis

Open access
Small, Peter M, Perkins, Mark D · 2000 · The Lancet
Cited by 63

The DOI matches its Crossref record.

Abstract

Of the roughly 8 million people who will develop tuberculosis this year, only a minority will get a laboratory-supported diagnosis. 1 Global Tuberculosis ControlWHO Report, 2000. WHO, Geneva2000 Google Scholar The insensitivity and laboriousness of sputum microscopy, a test fundamentally unchanged since its introduction in the 19th century, are the biggest obstacles to improving this situation. Inadequate tools for diagnosing tuberculosis also keep other critical subsets of patients from having access to targeted interventions, such as specific therapy for multidrug-resistant disease and treatment of latent infection. Why is the diagnostic armamentarium for one of the world's greatest public-health threats still reliant on antiquated approaches? Desired characteristics of new tests have been spelled out in some detail, 2 Foulds J O'Brien R New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis. 1998; 2: 778-783 PubMed Google Scholar , 3 Meeting Report. WHO Workshop on Tuberculosis Diagnostics, November, 1997. www.who.int/tdr/diseases/tb/pubs.htm (accessed on Sept 14, 2000). Google Scholar and recent advances in molecular biology, immunology, functional genomics, and nanotechniques have given birth to several promising assays. The new generation of candidate skintest reagents described by Peter Andersen and colleagues in this issue of The Lancet is representative of progress in the topic. Why have such research advances not resulted in important changes in the way tuberculosis is detected and managed? Why has there been so little progress in understanding how best to use new assays or what their potential impact might be on control of tuberculosis? A review of published work points the finger at the unsatisfactory design and execution of trials of diagnostic tests. Specific immune-based diagnosis of tuberculosisCurrent diagnostic tests for tuberculosis based on tuberculin have poor specificity, and both BCG vaccination and exposure to non-tuberculosis mycobacteria produce a response similar to that induced by infection with Mycobacterium tuberculosis. The identification of regions of the M tuberculosis genome that are not present in BCG and non-tuberculous mycobacteria provides a unique opportunity to develop new highly specific diagnostic reagents. We describe the current status of attempts to exploit this information and summarise recent research that has used defined antigens for an accurate and rapid test for tuberculosis infection based on the detection of T cells sensitised to M tuberculosis either by blood tests in vitro or skin tests in vivo. Full-Text PDF

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(00)02724-0

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 63

Metadata

Authors
Small, P. M., & Perkins, M. D.
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-09
Volume
356
Issue
9235
Pages
1048-1049
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2068818174
Cited by
63
References
0
FWCI
1.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: More rigour needed in trials of new diagnostic agents for tuberculosis. https://app.cochat.ai/papers/10.1016/s0140-6736(00)02724-0
The paper
Small, P. M., & Perkins, M. D. (2000). More rigour needed in trials of new diagnostic agents for tuberculosis. The Lancet. https://doi.org/10.1016/s0140-6736(00)02724-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.